Bushenkangshuai Tablet Reduces Atherosclerotic Lesion by Improving Blood Lipids Metabolism and Inhibiting Inflammatory Response via TLR4 and NF-κB Signaling Pathway

Bushenkangshuai tablet (BSKS) is a Chinese herbal compound which has been used for the treatment of cardiovascular and cerebrovascular diseases in China for decades. This study intends to explore the molecular mechanism of BSKS against atherosclerosis in ApoE(−/−) mice. ApoE(−/−) mice were fed with...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Shu-chao, Peng, Li, Zhang, Jun-ping, Wang, Yuan-yuan, Jia, Hui-yun, Bi, Li-yuan, Chen, Mei-ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829360/
https://www.ncbi.nlm.nih.gov/pubmed/29619063
http://dx.doi.org/10.1155/2018/1758383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829360/
https://www.ncbi.nlm.nih.gov/pubmed/29619063
http://dx.doi.org/10.1155/2018/1758383

Ejemplares similares